IPOX® 100 Europe Index (IPOE)
The IPOX® 100 Europe Index is an applied market cap-weighted index portfolio measuring the performance of the top 100 companies domiciled in developed European countries, ranked quarterly by market cap in the IPOX® Global Composite Index, subject to liquidity and exposure criteria. The index methodology also allows for the inclusion of U.S.-listed companies with European origins, ensuring comprehensive coverage of significant newly public European firms. The index has historically captured ca. 90% of total market cap created through European New Listings activity over the past four years, respectively.
The index and data is available for licensing as the basis for Financial Products,
including ETFs, Mutual Funds and Structured Products.
Please contact info@ipox.com for licensing opportunities.
The Best of European New Listings
The IPOX® 100 Europe Index showcases the breadth and dynamism of Europe’s newest public companies, bringing together a carefully balanced mix of established market leaders and innovative newcomers. Reflecting the latest trends across industries such as technology, healthcare, energy, finance, and consumer services, the index highlights how Europe’s capital markets continue to produce companies shaping the global economy. Its rules-based design and quarterly rebalancing ensure that it stays aligned with the evolving landscape of growth and innovation, offering a clear view into the momentum driving Europe’s “next generation” of publicly listed firms.
As the underlying benchmark for the First Trust IPOX® Europe Opportunities ETF (FPXE), it provides investors with an efficient way to follow the performance of this dynamic segment of the market.